Proposed biosimilar pegfilgrastim shows similarity in pharmacokinetics and pharmacodynamics to reference pegfilgrastim in healthy subjects.

MLA

Nakov, Roumen, et al. “Proposed Biosimilar Pegfilgrastim Shows Similarity in Pharmacokinetics and Pharmacodynamics to Reference Pegfilgrastim in Healthy Subjects.” British Journal of Clinical Pharmacology, vol. 84, no. 12, Dec. 2018, pp. 2790–801. EBSCOhost, https://doi.org/10.1111/bcp.13731.

APA

Nakov, R., Gattu, S., Wang, J., Velinova, M., Schaffar, G., & Skerjanec, A. (2018). Proposed biosimilar pegfilgrastim shows similarity in pharmacokinetics and pharmacodynamics to reference pegfilgrastim in healthy subjects. British Journal of Clinical Pharmacology, 84(12), 2790–2801. https://doi.org/10.1111/bcp.13731

Chicago

Nakov, Roumen, Sreekanth Gattu, Jessie Wang, Maria Velinova, Gregor Schaffar, and Andrej Skerjanec. 2018. “Proposed Biosimilar Pegfilgrastim Shows Similarity in Pharmacokinetics and Pharmacodynamics to Reference Pegfilgrastim in Healthy Subjects.” British Journal of Clinical Pharmacology 84 (12): 2790–2801. doi:10.1111/bcp.13731.